PR: WILEX AG: Subsidiary Heidelberg Pharma Signs Option Agreement with Max Delbrück Center
- PDF File: images/files/press-releases-and-ad-hoc-announcements/20160919_pm_lizenz-max-delbruck-zentrum_eng_final.pdf
- Datum: Monday, 19 September 2016 12:51
- Erstellt am .
- Geändert am .
- Aufrufe: 1353